Suppr超能文献

宫颈癌前的阴性细胞学检查:原因与预防

Negative cytology preceding cervical cancer: causes and prevention.

作者信息

Robertson J H, Woodend B

机构信息

Department of Cytopathology, Belfast City Hospital.

出版信息

J Clin Pathol. 1993 Aug;46(8):700-2. doi: 10.1136/jcp.46.8.700.

Abstract

AIM

To assess the validity of negative cervical smear reports in women who subsequently developed cervical cancer; and to determine means of improving the screening process.

METHODS

One hundred and forty cervical smears, initially reported as negative from 103 women, and taken up to 12 years before diagnosis of cervical cancer, were reviewed.

RESULTS

Ninety two smears contained dyskaryotic cells. Analysis showed that these smears formed several well defined patterns. False negative reports were likely to occur if fragments of neoplastic tissue rather than dissociated dyskaryotic cells were present or if the smear contained few dyskaryotic cells. Screening fatigue appeared to be a factor in others. It was also considered important that smears contained cells from the endocervix. These were deficient in 64% of the 47 smears confirmed as negative on review and in 69% of smears containing only a few dyskaryotic cells.

CONCLUSIONS

Current methods of quality assurance will not remedy these defects in the screening process. It is the responsibility of laboratories to identify sources of poor smears and liaise with smear takers to ensure an improvement in quality. Assessment of the quality of smears received by a laboratory should become an important part of audit. Staff training should place more emphasis on the interpretation of "microbiopsies". The adoption of a quick scanning technique before conventional screening would probably also substantially reduce false negative results.

摘要

目的

评估后续发生宫颈癌的女性宫颈涂片阴性报告的有效性;并确定改进筛查过程的方法。

方法

回顾了103名女性的140份宫颈涂片,这些涂片最初报告为阴性,且是在宫颈癌诊断前长达12年时采集的。

结果

92份涂片含有核异质细胞。分析表明,这些涂片形成了几种明确的模式。如果存在肿瘤组织碎片而非解离的核异质细胞,或者涂片含有的核异质细胞很少,则可能出现假阴性报告。筛查疲劳似乎是其他情况中的一个因素。宫颈管内膜细胞存在于涂片中也被认为很重要。在复查确认为阴性的47份涂片中,64%缺乏这些细胞,在仅含有少数核异质细胞的涂片中,69%缺乏这些细胞。

结论

当前的质量保证方法无法纠正筛查过程中的这些缺陷。实验室有责任识别劣质涂片的来源,并与涂片采集者联系以确保质量提高。对实验室收到的涂片质量进行评估应成为审核的重要组成部分。人员培训应更加强调对“微活检”的解读。在传统筛查前采用快速扫描技术可能也会大幅减少假阴性结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50bb/501451/f6381a17d109/jclinpath00209-0013-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验